Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term ox… Read more
Market Cap & Net Worth: Inogen Inc (INGN)
Inogen Inc (NASDAQ:INGN) has a market capitalization of $166.42 Million ($166.42 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16531 globally and #6343 in its home market, demonstrating a -1.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inogen Inc's stock price $6.13 by its total outstanding shares 27148482 (27.15 Million).
Inogen Inc Market Cap History: 2015 to 2026
Inogen Inc's market capitalization history from 2015 to 2026. Data shows change from $1.09 Billion to $166.42 Million (-17.53% CAGR).
Index Memberships
Inogen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.01% | #443 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #1541 of 3165 |
Weight: Inogen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Inogen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inogen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.74x
Inogen Inc's market cap is 0.74 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.09 Billion | $159.00 Million | $11.59 Million | 6.84x | 93.95x |
| 2016 | $1.82 Billion | $202.83 Million | $20.52 Million | 8.99x | 88.87x |
| 2017 | $3.23 Billion | $249.44 Million | $21.00 Million | 12.96x | 153.93x |
| 2018 | $3.37 Billion | $358.11 Million | $51.84 Million | 9.41x | 65.02x |
| 2019 | $1.86 Billion | $361.94 Million | $20.95 Million | 5.13x | 88.55x |
| 2020 | $1.21 Billion | $308.49 Million | -$5.83 Million | 3.93x | N/A |
| 2021 | $923.05 Million | $358.00 Million | -$6.33 Million | 2.58x | N/A |
| 2022 | $535.10 Million | $377.24 Million | -$83.77 Million | 1.42x | N/A |
| 2023 | $149.05 Million | $315.66 Million | -$102.45 Million | 0.47x | N/A |
| 2024 | $248.95 Million | $335.70 Million | -$35.89 Million | 0.74x | N/A |
Competitor Companies of INGN by Market Capitalization
Companies near Inogen Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Inogen Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Inogen Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Inogen Inc's market cap moved from $1.09 Billion to $ 166.42 Million, with a yearly change of -17.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $166.42 Million | -8.78% |
| 2025 | $182.44 Million | -26.72% |
| 2024 | $248.95 Million | +67.03% |
| 2023 | $149.05 Million | -72.15% |
| 2022 | $535.10 Million | -42.03% |
| 2021 | $923.05 Million | -23.90% |
| 2020 | $1.21 Billion | -34.61% |
| 2019 | $1.86 Billion | -44.97% |
| 2018 | $3.37 Billion | +4.27% |
| 2017 | $3.23 Billion | +77.28% |
| 2016 | $1.82 Billion | +67.55% |
| 2015 | $1.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Inogen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $166.42 Million USD |
| MoneyControl | $166.42 Million USD |
| MarketWatch | $166.42 Million USD |
| marketcap.company | $166.42 Million USD |
| Reuters | $166.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.